IndraLab

Statements


USP18 activates LC3-II. 2 / 2
| 2

reach
"Consistent with the role of USP18 as a negative regulator of type I IFN signaling,6 knockdown of USP18 further potentiated the reduction of LC3-II induced by type I IFN."

reach
"Overexpression of USP18 led to upregulation of LC3-II and downregulation of SQSTM1 in a dose dependent manner."